Newsfeed

Cancer treatment can be physically and emotionally difficult. Many patients experience symptoms like pain, tiredness (fatigue), anxiety, and depression, which affect their daily lives. The…

Breast cancer risk varies from person to person, especially for those with inherited genetic mutations (changes in DNA passed down from parents). Recent research has…

Pancreatic cancer is difficult to detect in its early stages, which often leads to late diagnoses and lower survival rates. Researchers have developed a new…

A recent study, published in Cancer Immunology Research, explored a protein called Natural Killer Cell Granule Protein 7 (NKG7) and its role in cancer treatment.…

Researchers have identified critical genetic factors that drive lung squamous cell carcinoma (LUSC), a type of lung cancer that starts in the thin, flat squamous…

Led by Christi A. Patten, Ph.D., Mayo Clinic's Rural Health Research Core (RHRC), is dedicated to supporting underserved rural populations across Iowa, Minnesota, and Wisconsin.…

The Community Outreach and Engagement (COE) Office at Mayo Clinic Comprehensive Cancer Center continues to expand its Global Oncology Initiatives (GOI), cultivating meaningful collaborations and…

At the Cancer Support Community Arizona (CSCAZ), the mission is clear: no one should face cancer alone. Lilian Fonseca, Director of Community Outreach and Engagement, is…

Deisy Cañón Lovera manages the Southern Minnesota region for Hispanic Advocacy and Community Empowerment Through Research (HACER) in Mankato, Minnesota. Since 2023, she has served on the…

Many patients struggle to access advanced cancer treatments, especially those in rural communities or with limited financial resources. By developing shorter radiation schedules, we can…

Each year, more than 288,000 men in the U.S. are diagnosed with prostate cancer. By 2040, this number could double. Researchers at Mayo Clinic have…

Researchers have made important progress in treating colorectal cancer (CRC) by combining two drugs, tucatinib and trastuzumab, to target a specific type of cancer called…